Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Scientific Reports|July 4, 2020
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastasesMichele Basso, Salvatore Corallo, Maria Alessandra Calegari, et al.
Targeted Oncology|April 13, 2024
Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective AnalysisMichele Basso, Carlo Signorelli, Maria Alessandra Calegari, et al.
Journal of Neurotrauma|February 24, 2017
Targeting Translational Successes through CANSORT-SCI: Using Pet Dogs To Identify Effective Treatments for Spinal Cord InjurySarah A Moore, Nicolas Granger, Natasha J Olby, et al.
The Oncologist|November 17, 2025
Long-term survival and prognostic factors after repeated metastasectomies in metastatic colorectal cancer: a 15-years retrospective studyGiovanni Trovato, Francesco Schietroma, Laura Chiofalo, et al.
Scientific Reports|April 10, 2021
Endovascular repair and open repair surgery of thoraco-abdominal aortic aneurysms cause drastically different types of spinal cord injuryHamdy Awad, Esmerina Tili, Gerard Nuovo, et al.
Annals of Diagnostic Pathology|July 4, 2018
MiR-155 deletion reduces ischemia-induced paralysis in an aortic aneurysm repair mouse model: Utility of immunohistochemistry and histopathology in understanding etiology of spinal cord paralysisHamdy Awad, Anna Bratasz, Gerard Nuovo, et al.
Clinical Colorectal Cancer|January 24, 2025
Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter CohortJessica Lucchetti, Lorenzo Angotti, Alessandro Parisi, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective StudyCarlo Signorelli, Maria Alessandra Calegari, Michele Basso, et al.
Cancers|December 23, 2023
Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup AnalysisCarlo Signorelli, Mario Giovanni Chilelli, Diana Giannarelli, et al.
World Journal of Hepatology|January 24, 2018
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinomaFrancesca Romana Ponziani, Irene Spinelli, Emanuele Rinninella, et al.
Pageof 13